Substituted arylcylopentenes as therapeutic agents

Details for Australian Patent Application No. 2008208032 (hide)

Owner Allergan, Inc.

Inventors Ngo, Vinh X.; Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2008208032

PCT Pub. Number WO2008/091810

Priority 60/886,018 22.01.07 US

Filing date 21 January 2008

Wipo publication date 31 July 2008

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/381 (2006.01) - having five-membered rings

C07D 333/16 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/091810 Priority application(s): WO2008/091810

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008208040-Metallothermic reduction of in-situ generated titanium chloride

2008208029-Guayule harvester